This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Raveendra Pai: Innovator in Respiratory Treatment
Introduction
Raveendra Pai is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of respiratory medicine through his innovative inventions. His work focuses on improving the delivery of medication for respiratory disorders.
Latest Patents
Raveendra Pai holds a patent for a metered dose inhaler designed for ipratropium bromide solution. This invention relates to a metered dose inhaler device that comprises a stable inhalable composition of ipratropium bromide. The device is contained in a canister fitted with a metering valve, an actuator, and a dose indicator. The invention also includes a process for preparing such a pharmaceutical composition and its application in treating respiratory disorders, particularly for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
Career Highlights
Raveendra Pai is currently associated with Glenmark Pharmaceuticals Limited, where he continues to work on innovative solutions for respiratory health. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.
Collaborations
Some of his coworkers include Ashok Katkurwar and Ulhas R Dhuppad, who contribute to the collaborative efforts in advancing respiratory treatment technologies.
Conclusion
Raveendra Pai's contributions to the field of respiratory medicine through his innovative inventions highlight the importance of research and development in improving patient care. His work continues to impact the lives of individuals suffering from respiratory disorders.